This one-time gene therapy targets the root cause of SCID, providing a lasting solution rather than ongoing treatment.Newatlas• 5 min
A groundbreaking gene therapy has successfully cured 95% of children suffering from Severe Combined Immunodeficiency (SCID), commonly known as 'bubble boy' disease, marking a significant advancement in medical treatment. For more details, check the full story here.